Sarepta Therapeutics Receives FDA Rejection, Shares Dip
The company's share price dropped by more than 20 percent after the decision from the regulatory...
August 20th, 2019
Myriad Genetics Tumbles on Fiscal Q4 and 2019 Results
Shares of Myriad Genetics dropped over 40 percent following the release of its latest quarterly and...
August 14th, 2019
Sarepta Dips on “Erroneous” Report to FDA
The company's share price dropped as much as 10 percent in midday trading on Thursday. It...
August 8th, 2019
FAQ
![]()
What is Genetics Investing?
Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the...
July 22nd, 2019
5 Gene Therapy Stocks for Investors
What gene therapy companies should be on investors' radar? Here are five companies developing a wide...
July 18th, 2019
FAQ
![]()
6 Top Genetic Testing Stocks
Looking to invest in genetic testing? Or learn more about the companies involved? Here are six...
June 26th, 2019
Organovo Shares Spike on Kidney Disease Treatment Collaboration
Organovo climbed over 100 percent on the news that it will develop 3D bioprinted stem cell-based...
May 30th, 2019